# A Study to Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin

> **NCT02452632** · PHASE3 · COMPLETED · sponsor: **Astellas Pharma Korea, Inc.** · enrollment: 143 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** ASP1941
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02452632
- **Lead sponsor:** Astellas Pharma Korea, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06-22
- **Primary completion:** 2017-01-05
- **Final completion:** 2017-01-05
- **Target enrollment:** 143 (ACTUAL)
- **Last updated:** 2024-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02452632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02452632, "A Study to Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02452632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*